Vontier Corporation (VNT)
NYSE: VNT · Real-Time Price · USD
40.55
+0.18 (0.45%)
Aug 8, 2025, 4:00 PM - Market closed
ASLAN Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 27, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2020 |
Net Income | 395.1 | 422.2 | 376.9 | 401.3 | 413 | 342 | Upgrade |
Depreciation & Amortization | 129.1 | 127.1 | 125 | 118.9 | 88.3 | 78.3 | Upgrade |
Other Amortization | - | - | - | - | 6.8 | 0.8 | Upgrade |
Loss (Gain) From Sale of Assets | - | -37.2 | -34.4 | - | - | -2.7 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 85.3 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | -24 | -3.3 | - | Upgrade |
Stock-Based Compensation | 30.3 | 31.6 | 31.5 | 24.3 | 25.5 | 22.5 | Upgrade |
Other Operating Activities | 10.3 | 3.3 | 3.4 | 11.9 | 6.8 | - | Upgrade |
Change in Accounts Receivable | -170.9 | -203.9 | -148.1 | -217.2 | -140.4 | -92.8 | Upgrade |
Change in Inventory | -48.5 | -48.5 | 48.9 | -74.3 | -34.6 | -7 | Upgrade |
Change in Accounts Payable | 14.9 | 14.9 | -66.8 | 21.3 | 45.6 | 44.1 | Upgrade |
Change in Other Net Operating Assets | 172.8 | 150.8 | 165.9 | 100.2 | 118.6 | 256.2 | Upgrade |
Operating Cash Flow | 500.3 | 427.5 | 455 | 321.2 | 481.1 | 691.3 | Upgrade |
Operating Cash Flow Growth | 15.25% | -6.04% | 41.66% | -33.24% | -30.41% | 26.80% | Upgrade |
Capital Expenditures | -73.1 | -82.7 | -60.1 | -60 | -47.8 | -35.7 | Upgrade |
Sale of Property, Plant & Equipment | 4.7 | 5.6 | 4.5 | 0.4 | - | 3.5 | Upgrade |
Cash Acquisitions | -10.3 | - | - | -277.5 | -955.8 | - | Upgrade |
Divestitures | - | 68.4 | 107.5 | - | - | - | Upgrade |
Investment in Securities | -1.3 | -2.7 | 17.4 | 7.2 | -11.3 | -9.5 | Upgrade |
Other Investing Activities | - | - | - | - | 7.2 | - | Upgrade |
Investing Cash Flow | -80 | -11.4 | 69.3 | -329.9 | -1,008 | -41.7 | Upgrade |
Short-Term Debt Issued | - | - | 1.9 | 0.4 | - | - | Upgrade |
Long-Term Debt Issued | - | - | - | 1,167 | 2,187 | 1,800 | Upgrade |
Total Debt Issued | 83.3 | - | 1.9 | 1,167 | 2,187 | 1,800 | Upgrade |
Short-Term Debt Repaid | - | -4.5 | - | - | -7 | -5.3 | Upgrade |
Long-Term Debt Repaid | - | -150 | -300 | -1,167 | -1,400 | -23.4 | Upgrade |
Total Debt Repaid | -188.1 | -154.5 | -300 | -1,167 | -1,407 | -28.7 | Upgrade |
Net Debt Issued (Repaid) | -104.8 | -154.5 | -298.1 | 0.4 | 779.5 | 1,771 | Upgrade |
Issuance of Common Stock | 6.4 | 17 | 10.4 | 2.5 | 7.5 | 1.6 | Upgrade |
Repurchase of Common Stock | -270.1 | -224.7 | -74.7 | -328 | - | - | Upgrade |
Common Dividends Paid | -14.9 | -15.2 | -15.5 | -15.9 | -12.7 | - | Upgrade |
Other Financing Activities | -16 | -14.9 | -9.9 | -6.9 | -48.8 | -2,057 | Upgrade |
Financing Cash Flow | -399.4 | -392.3 | -387.8 | -347.9 | 725.5 | -283.9 | Upgrade |
Foreign Exchange Rate Adjustments | 12 | -8.3 | -0.1 | -11.5 | -6.8 | 14.8 | Upgrade |
Net Cash Flow | 32.9 | 15.5 | 136.4 | -368.1 | 192.1 | 380.5 | Upgrade |
Free Cash Flow | 427.2 | 344.8 | 394.9 | 261.2 | 433.3 | 655.6 | Upgrade |
Free Cash Flow Growth | 19.97% | -12.69% | 51.19% | -39.72% | -33.91% | 29.26% | Upgrade |
Free Cash Flow Margin | 14.05% | 11.57% | 12.76% | 8.20% | 14.49% | 24.24% | Upgrade |
Free Cash Flow Per Share | 2.84 | 2.24 | 2.53 | 1.62 | 2.55 | 3.87 | Upgrade |
Cash Interest Paid | 75.6 | 75.6 | 94.7 | 67.5 | 37.1 | 5.9 | Upgrade |
Cash Income Tax Paid | 93.5 | 93.5 | 126 | 167.2 | 218.3 | 4.6 | Upgrade |
Levered Free Cash Flow | 353.66 | 357.28 | 484.01 | 149.08 | 412.39 | 609.85 | Upgrade |
Unlevered Free Cash Flow | 396.23 | 403.96 | 542.58 | 192.58 | 435.46 | 615.3 | Upgrade |
Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.